Donor-directed immunologic safety of COVID-19 vaccination in renal transplant recipients

Infection risk and COVID-19 outcomes make SARS-CoV-2 vaccination essential for solid-organ transplant recipients. Reports of immune activation after vaccination causing graft failure raise concerns, but data are limited. Here, we document graft function, donor-derived-cell-free-DNA(dd-cfDNA), and do...

Descripción completa

Detalles Bibliográficos
Autores principales: Kueht, Michael, Kirk, Katie, Scott Lea, A, Stevenson, Heather L, Fair, Jeff, Kathleen Gamilla-Crudo, A., Hussain, Syed, Mujtaba, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279300/
https://www.ncbi.nlm.nih.gov/pubmed/35871882
http://dx.doi.org/10.1016/j.humimm.2022.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279300/
https://www.ncbi.nlm.nih.gov/pubmed/35871882
http://dx.doi.org/10.1016/j.humimm.2022.07.002

Ejemplares similares